ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $622,000 | -82.0% | 52,800 | -79.1% | 0.02% | -81.7% |
| Q1 2019 | $3,456,000 | -9.3% | 253,200 | -31.9% | 0.12% | -18.4% |
| Q4 2018 | $3,810,000 | -35.3% | 371,700 | +5.1% | 0.15% | -43.9% |
| Q3 2018 | $5,889,000 | +383.9% | 353,700 | +359.4% | 0.26% | +297.0% |
| Q2 2018 | $1,217,000 | -47.1% | 77,000 | -57.5% | 0.07% | -61.8% |
| Q1 2018 | $2,301,000 | +272.9% | 181,234 | +236.5% | 0.17% | +170.3% |
| Q2 2017 | $617,000 | -60.4% | 53,865 | -28.2% | 0.06% | -59.0% |
| Q1 2017 | $1,560,000 | +411.5% | 75,000 | +704.6% | 0.16% | +200.0% |
| Q3 2016 | $305,000 | +32.6% | 9,321 | +1.2% | 0.05% | +2.0% |
| Q2 2016 | $230,000 | – | 9,215 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |